Zantac Users Push To Consolidate Calif. Cancer Suits

Law360 (June 9, 2020, 7:09 PM EDT) -- Attorneys representing 40 people with cancer who allege that Sanofi-Aventis US LLC, Pfizer Inc. and other pharmaceutical companies hid the risks that heartburn drug Zantac could produce a carcinogen are asking to have their cases consolidated in California.

In a petition filed Monday, the plaintiffs in the 40 cases asked to have their suits linked in a judicial council coordinated proceeding to consolidate pretrial and trial phases of the cases, which they said would work alongside the existing Zantac multidistrict litigation in Florida.

"Coordinating these two important proceedings is the first step in putting pressure on these defendants to come to...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!